ARTHRITIS PAIN FORMULA

Manufacturer: Hyland's | Standard Homeopathic Company
Effective date: 2017-12-09
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: legacy-cache
Hydrated at: 2026-08-02 01:06:01

Label at a glance#

ProductARTHRITIS PAIN FORMULA

Active ingredientARNICA MONTANA, BLACK COHOSH, GUAIACUM OFFICINALE RESIN, BRYONIA ALBA ROOT, TOXICODENDRON PUBESCENS LEAF

Label structure7 sections

Dosage and administration

Dissolve 2 - 3 tablets under tongue every 4 hours or as needed.

Label contents#

Full prescribing information#

OTC - PURPOSE SECTION

Formerly Hyland's #21, Hyland's Arthritis Pain Formaula is a traditional homeopathic formula for the relief of symptoms of pain in joints associated with minor arthritis symptoms. Also indicated for minor muscular pain associated with over-exertion, especially in back and neck. Working without contraindications or side effects, Hyland's Arthritis Pain Formula stimulates your body's natural healing response to relieve symptoms. Hyland's Arthritis Pain Formula can be used in conjuction with other medications.

Warnings

WARNINGS SECTION

OTC - DO NOT USE SECTION

Do not use if imprinted tamper band is broken or missing.

OTC - ASK DOCTOR SECTION

If symptoms persist for more than seven days or worsen, contact a licensed health care professional.

OTC - PREGNANCY OR BREAST FEEDING SECTION

As with any drug, if you are pregnant or nursing a baby, seek the advice of a licensed health care professional before using this product.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this and all medications out of the reach of children.

SPL UNCLASSIFIED SECTION

In case of accidental overdose, contact a poison control center immediately.

Indications

INDICATIONS & USAGE SECTION

Relief of symptoms of pain in joints associated with minor arthritis symptoms. Also indicated for minor muscular pain associated with overexertion, especially in back and neck.

Directions

DOSAGE & ADMINISTRATION SECTION

Adults

SPL UNCLASSIFIED SECTION

Dissolve 2 - 3 tablets under tongue every 4 hours or as needed.

FORMULA

OTC - ACTIVE INGREDIENT SECTION

ARNICA MONTANA 6X, HPUS; CIMICIFUGA RACEMOSA 3X, HPUS; GUAIACUM 3X, HPUS; BRYONIA 3X, HPUS; RHUS TOXICODENDRON 6X, HPUS

INACTIVE INGREDIENT SECTION

IN A BASE OF ACACIA GUM, LACTOSE N.F.

QUESTIONS?

OTC - QUESTIONS SECTION

800/624-9659

PRINCIPAL DISPLAY PANEL - 100 Tablet Bottle Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 54973-2955-02

Hyland's®

HOMEOPATHIC

ARTHRITIS
PAIN

FORMULA

Natural Relief for Minor

Muscle and Joint Pain.

100

TABLETS

carton

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ARNICA MONTANA	ACTIVE INGREDIENT	O80TY208ZW	1
BLACK COHOSH	ACTIVE INGREDIENT	K73E24S6X9	1
BRYONIA ALBA ROOT	ACTIVE INGREDIENT	T7J046YI2B	1
GUAIACUM OFFICINALE RESIN	ACTIVE INGREDIENT	N0K2Z502R6	1
TOXICODENDRON PUBESCENS LEAF	ACTIVE INGREDIENT	6IO182RP7A	1
ARNICA MONTANA	ACTIVE MOIETY	O80TY208ZW	1
BLACK COHOSH	ACTIVE MOIETY	K73E24S6X9	1
BRYONIA ALBA ROOT	ACTIVE MOIETY	T7J046YI2B	1
GUAIACUM OFFICINALE RESIN	ACTIVE MOIETY	N0K2Z502R6	1
TOXICODENDRON PUBESCENS LEAF	ACTIVE MOIETY	6IO182RP7A	1
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

ARTHRITIS PAIN FORMULA
arnica montana, black cohosh, guaiacum officinale resin, bryonia alba root, and toxicodendron pubescens leaf
LACTOSE
ARNICA MONTANA
BLACK COHOSH
GUAIACUM OFFICINALE RESIN
BRYONIA ALBA ROOT
TOXICODENDRON PUBESCENS LEAF

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
54973-2955	54973-2955-1, 54973-2955-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
LACTOSE	J2B2A4N98G	IACT
ARNICA MONTANA	O80TY208ZW	ACTIB
BLACK COHOSH	K73E24S6X9	ACTIB
GUAIACUM OFFICINALE RESIN	N0K2Z502R6	ACTIB
BRYONIA ALBA ROOT	T7J046YI2B	ACTIB
TOXICODENDRON PUBESCENS LEAF	6IO182RP7A	ACTIB

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 36 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION / INTRAMUSCULAR	203.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION / INTRAVENOUS	203.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CONCENTRATE / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, COATED / ORAL	332.05 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EFFERVESCENT / ORAL	96.5 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	FILM, EXTENDED RELEASE / TRANSDERMAL	675 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	GRANULE, FOR SUSPENSION / ORAL	512.5 mg/5ml		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER / RESPIRATORY (INHALATION)	90 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER / VAGINAL	430 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED PELLETS / ORAL	135.2 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, SOLUTION / INTRAVENOUS	0.45 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / RECTAL	20 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	OINTMENT / TOPICAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CREAM / VAGINAL	3 %w/w		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EXTENDED RELEASE / ORAL	400 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SOLUTION / RECTAL	8 %w/v		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE / ORAL	530 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / SUBLINGUAL		352 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, DELAYED RELEASE / ORAL		160 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, CHEWABLE / ORAL		1412 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		620 mg	Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY	193.8 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED / ORAL	590 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE / RESPIRATORY (INHALATION)	44.4 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / BUCCAL	296.7 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, EXTENDED RELEASE / ORAL	120 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SOLUTION / ORAL	1682 mg/15ml		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, DELAYED RELEASE / ORAL	231.84 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / ORAL	2500 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS	133 mg		Exact identifier — unii candidate 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER, FOR SOLUTION / ORAL	NA		Exact identifier — unii candidate 36 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
d39e7479-888b-60fa-e053-2a95a90aa04b			a803452d-b031-4ba1-b14a-8dd07e978463	2021-12-20	Warnings	Exact identifier spl set id: a803452d-b031-4ba1-b14a-8dd07e978463

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.